Wed.Oct 09, 2024

article thumbnail

STAT+: UnitedHealth, CVS ask judge to remove Lina Khan from FTC’s insulin-price lawsuit

STAT

UnitedHealth Group and CVS Health have petitioned a federal judge to sideline Federal Trade Commission Chair Lina Khan and the two Democratic FTC commissioners from the agency’s lawsuit against the country’s largest pharmacy benefit managers. Attorneys for UnitedHealth’s Optum Rx and CVS Caremark contend Khan, Rebecca Kelly Slaughter, and Alvaro Bedoya “have made repeated incorrect prejudgments” about the PBMs as well as their group purchasing organizations tha

article thumbnail

As AI transforms drug development, biotechs might not need as much Big Pharma support

PharmaVoice

Small biotechs are making gains with AI drug development, and their advantages may help some push ahead without Big Pharma.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: As U.S. efforts stall, China pushes ahead with CRISPR treatments for muscular dystrophy

STAT

Two of the first efforts to treat Duchenne muscular dystrophy with CRISPR gene editing are getting off the ground in China, even as projects in the U.S. have seemingly stalled. Trials for the fatal muscle-wasting disease were started in the last couple of months by two different Chinese companies. One, GenAssist, has already dosed one young boy. Huidagene, the other biotech, expects to dose the first of three boys soon and report data by Q1 next year.

355
355
article thumbnail

Purespring Therapeutics secures £80 million in Series B funding

Pharma Times

New investment to advance gene therapies for kidney diseases

144
144
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

2024 Nobel Prize in chemistry: Three scientists win for groundbreaking work in proteins

STAT

LONDON — A trio of scientists who opened new doors in our understanding of the structure of proteins — the fundamental building blocks of biology — and even came up with ways to create new proteins won the Nobel Prize in chemistry Wednesday. The prize went to David Baker of the University of Washington, and to Demis Hassabis and John Jumper, who work at Google DeepMind in London.

346
346
article thumbnail

Sanofi launches high-dose flu vaccine in the UK

Pharma Times

New vaccine aims to protect older adults from severe flu complications

Vaccines 135

More Trending

article thumbnail

Fulfilling My Purpose as a Future Bilingual Pharmacist – Honoring Hispanic Heritage in Pharmacy

Pharmacy Is Right For Me

Hello everyone, my name is Diana Martinez-Nava and I am a fourth-year student pharmacist at The University of New Mexico College of Pharmacy. I would like to take some time on this special month celebrating our Hispanic Heritage to share my story on my pharmacy journey. My interest in becoming a pharmacist began around the time I was 8 years old. I was that small child who could barely see over the counter at our neighborhood pharmacy next to my father’s arm who would be reaching out to collect,

Diabetes 130
article thumbnail

STAT+: Medicare already covers GLP-1s for half of seniors with obesity, new report finds

STAT

WASHINGTON — A new report from congressional budget experts this week estimated that it would cost Medicare an additional $35 billion over nine years if the program began covering GLP-1 drugs for obesity. But the report also noted that half of seniors who would qualify for obesity coverage already have access to the drugs for other conditions.

Diabetes 330
article thumbnail

Practice pharmacists 'well placed' to lead on new repeat prescribing tool

The Pharmacist

New national repeat prescribing guidance has been published in a bid to improve consistency and patient safety – and practice pharmacists have been described as 'well placed' to lead its implementation. The Royal Pharmaceutical Society (RPS) and the Royal College of GPs (RCGP) have this week launched a new repeat prescribing toolkit, in what is […] The post Practice pharmacists 'well placed' to lead on new repeat prescribing tool appeared first on The Pharmacist.

124
124
article thumbnail

STAT+: Q&A: How the FDA is approaching AI in clinical trials and drug development

STAT

In the last year, pharma incumbents have leaned into partnerships with AI-driven startups to supercharge drug discovery efforts. High-powered models of protein structure and molecule binding can help identify new disease targets, and even help design new drugs. But AI-derived or not, a new drug candidate still has to wind its way through the painstaking clinical trial process.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Advancing Precision Care For All

pharmaphorum

Advancing Precision Care For All with Hakim Yadi from Closed Loop Medicine. Listen to the latest podcast episode featuring insights from a leader in the healthcare industry.

124
124
article thumbnail

STAT+: GSK to pay $2.2 billion to settle most Zantac lawsuits over claims the heartburn pill causes cancer

STAT

After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer. The settlement covers roughly 80,000 cases, or 93% of the suits that were outstanding in state courts around the U.S. At the same time, the company agreed to pay $70 million to settle a whistleblower lawsuit that was filed by Valisure, an independent laboratory that alleged GSK concealed the link between t

320
320
article thumbnail

Importance of choosing the right POC marketing partners in healthcare

pharmaphorum

Choosing the right POC (point of care) marketing partners in healthcare is crucial for reaching healthcare professionals (HCP) effectively. Learn about the importance and benefits of selecting the right partners in this essential marketing strategy.

122
122
article thumbnail

STAT+: Eli Lilly, Insitro ink a new kind of AI drug development deal

STAT

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent deals between burgeoning artificial intelligence upstarts and established pharma giants: After identifying drug candidates, Insitro will be responsible for commercializing the drugs, and Lilly will be eligible for milestones and royalties.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The future of multiple myeloma is personalised, but we must work together to deliver it

pharmaphorum

The future of multiple myeloma treatment is personalised, but collaboration is essential to deliver it. Learn about the latest advancements and how working together can improve outcomes for patients.

119
119
article thumbnail

Prime Medicine lays off workers as it trims pipeline

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning to everyone except the Empire State Building.

article thumbnail

From Chaos to Clarity: Streamlining Your Generic Drug Portfolio

Drug Patent Watch

The pharmaceutical industry plays a crucial role in global healthcare, providing essential medications that improve and save lives. Within this industry, generic pharmaceuticals are particularly important due to their affordability and accessibility.

117
117
article thumbnail

STAT+: Epic Systems v. Particle: What the Carequality investigation reveals about the dispute

STAT

Late Tuesday night, Carequality released new information about its investigation into the dispute between electronic health records vendor Epic Systems and health data startup Particle Health that has now escalated into an antitrust lawsuit. The dispute between the two started earlier in the year when Epic accused Particle of requesting and sharing health data with customers in violation of Carequality’s rules.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Do HCPs really want the return of in-person meetings?

pharmaphorum

Discover if healthcare professionals prefer the return of in-person meetings or are embracing virtual alternatives instead. Explore the benefits and challenges of virtual events for HCPs.

114
114
article thumbnail

Opinion: STAT+: Traditional randomized trials don’t work for ultra-rare diseases like Barth syndrome

STAT

Another ultra-rare therapy will soon be subject to the gaze of an FDA advisory committee, with the fate of more than 200 boys diagnosed with Barth syndrome worldwide in the balance. On Thursday, the FDA cardiovascular and renal drugs advisory committee will be reviewing a new drug application for elamipretide hydrochloride injection , submitted by Stealth BioTherapeutics Inc., for the treatment of Barth syndrome.

261
261
article thumbnail

AI startup Basecamp allies with the Broad to dream up ‘programmable’ genetic medicines

BioPharma Dive

The company, which is building a database of biological interactions found in nature, revealed $60 million in funding and a collaboration with David Liu’s lab.

113
113
article thumbnail

The Chemistry Nobel, new youth mental health stats, and viruses in your bathroom

STAT

Good morning, it’s Wednesday! A few of us at STAT thought yesterday might have been Wednesday, but no, it’s today. And in case you’re as confused as us, tomorrow is Thursday. (You would think editing a weekly podcast keeps me aware of what day it is, but you’d be wrong.) There are only 11 weeks left in 2024 … ! Anyway, the news: Chemistry Nobel goes to three scientists for protein discoveries Scientists who opened new doors in our understanding of the structure

222
222
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

GSK says $2.2bn settlement resolves most Zantac litigation

pharmaphorum

GSK says a $2.

111
111
article thumbnail

Using de-identified lab data to find patients, target physicians and expedite treatment

BioPharma Dive

Many pharma companies are now using de-identified lab data to identify potential patients and their physicians in time to impact the patient’s treatment plan. In this Q&A, learn how lab data can be used to increase patient access.

98
article thumbnail

Lilly names Thomas Fuchs as its first chief AI officer

pharmaphorum

Lilly names Thomas Fuchs as its first chief AI officer Phil.

109
109
article thumbnail

Could preventative care save the future of the NHS?

Pharmaceutical Technology

As a major report highlights the challenges of a struggling NHS, the call for preventative care is growing in the UK.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ex-Pfizer leaders side with firm against activist investor

pharmaphorum

Ex-Pfizer CEO and finance chief withdraw support for Starboard Value campaign seeking a change in strategy at the pharma group.

105
105
article thumbnail

Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond

Drug Channels

As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. During this period of volatility, the core business model of the Big Three public pharmaceutical distribution companies—Cardinal Health, Cencora, and McKesson—remains intact.

article thumbnail

Sage takes another hit as Alzheimer's drug is canned

pharmaphorum

Sage Therapeutics stops development of dalzanemdor in Alzheimer's, a few months after pulling the plug on the drug in Parkinson's

105
105
article thumbnail

Esophageal Varices Prophylaxis – Selecting a Beta-Blocker

Med Ed 101

Esophageal varices are large veins in the lower part of the esophagus that can be caused by portal hypertension which is a complication of liver disease. When stressed, these varices can rupture leading to excessive bleeding. The first line treatment for esophageal varices prophylaxis is the non-selective beta-blockers (NSBB). The portal vein, the vein that […] The post Esophageal Varices Prophylaxis – Selecting a Beta-Blocker appeared first on Med Ed 101.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.